Who has invested in NBE-Therapeutics?

Boehringer Ingelheim Venture Fund are named among the investors backing NBE-Therapeutics.

NBE-Therapeutics Funding: $79M Raised, Series A (2015)

NBE-Therapeutics funding overview

NBE-Therapeutics is based in Basel, Switzerland. NBE-Therapeutics has raised $79M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in March 2015. The round record for NBE-Therapeutics runs through 2015; nothing later has been disclosed. Investors on record include Boehringer Ingelheim Venture Fund.

NBE-Therapeutics at a glance

Total raised: $79M
Latest round: Series A
Latest round date: March 2015
Headquarters: Basel, Switzerland
Notable investors: Boehringer Ingelheim Venture Fund

Frequently asked about NBE-Therapeutics funding

How much has NBE-Therapeutics raised?: NBE-Therapeutics has raised $79M in total disclosed funding across the rounds on record.
Who has invested in NBE-Therapeutics?: Boehringer Ingelheim Venture Fund are named among the investors backing NBE-Therapeutics.
What was the latest NBE-Therapeutics funding round?: The most recent disclosed round is a Series A, announced in March 2015.
Where is NBE-Therapeutics based?: NBE-Therapeutics is based in Basel, Switzerland.
When did NBE-Therapeutics last raise?: The last disclosed NBE-Therapeutics round closed in March 2015 at Series A.

Round data for NBE-Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Basel and backer lists below.

NBE-Therapeutics Funding: $79M Raised, Series A (2015)

NBE-Therapeutics funding overview

NBE-Therapeutics at a glance

Frequently asked about NBE-Therapeutics funding

Companies related to NBE-Therapeutics (30)

Browse related funding lists (4)